查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1420923

癌症恶病质市场 - 2023-2031 年全球产业分析、规模、份额、成长、趋势和预测

Cancer Cachexia Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 218 Pages | 商品交期: 2-10个工作天内

价格

癌症恶病质市场 - 报告范围

TMR 关于全球癌症恶病质市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球癌症恶病质市场的收入2017-2031年期间，考虑2023年为基准年，2031年为预测年。报告中也提供了2023年至2031年全球癌症恶病质市场的年复合成长率（CAGR %）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解癌症恶病质市场。

市场概况
2023年市场价值 22亿美元
2031 年市场价值 36 亿美元
CAGR 4.7%

该报告深入研究了全球癌症恶病质市场的竞争格局。全球癌症恶病质市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概述、财务状况、最新发展和 SWOT 是本报告中介绍的全球癌症恶病质市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2023-2031年全球市场分析与预测

第 5 章：关键见解

  • 管道分析
  • 主要产品/品牌分析
  • 主要併购
  • COVID-19 大流行对该行业的影响

第 6 章：全球市场分析与预测：依治疗学分类

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依疗法分类，2023-2031
    • 黄体素
    • 皮质类固醇
    • 联合疗法
    • 其他的
  • 市场吸引力分析：依治疗学分类

第 7 章：全球市场分析与预测：按作用机制

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按作用机制，2023-2031
    • 食慾刺激器
    • 减肥稳定剂
    • 其他的
  • 市场吸引力分析：按作用机制

第 8 章：全球市场分析与预测：按配销通路

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按配销通路，2023-2031
    • 医院商店
    • 零售药局
    • 网路药局
  • 市场吸引力分析：按作用机制

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2023-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • Aeterna Zentaris, Inc.
    • Alder BioPharmaceuticals Inc.
    • Aphios Corporation
    • Eli Lilly and Company
    • GTx Inc.
    • Helsinn Group
    • Merck & Co. Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company
    • XBiotech, Inc.
Product Code: TMRGL15482

Cancer Cachexia Market - Scope of Report

TMR's report on the global cancer cachexia market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global cancer cachexia market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cancer cachexia market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the cancer cachexia market.

Market Snapshot
Market Value in 2023US$ 2.2 Bn
Market Value in 2031US$ 3.6 Bn
CAGR4.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cancer cachexia market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cancer cachexia market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cancer cachexia market.

The report delves into the competitive landscape of the global cancer cachexia market. Key players operating in the global cancer cachexia market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cancer cachexia market profiled in this report.

Key Questions Answered in Global cancer cachexia Market Report:

  • What is the sales/revenue generated by cancer cachexia across all regions during the forecast period?
  • What are the opportunities in the global cancer cachexia market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Cancer Cachexia Market - Research Objectives and Research Approach

The comprehensive report on the global cancer cachexia market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cancer cachexia market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cancer cachexia market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cancer Cachexia Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Cancer Cachexia Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Cancer Cachexia Market Analysis and Forecast, by Therapeutics

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 6.3.1. Progestogens
    • 6.3.2. Corticosteroids
    • 6.3.3. Combination Therapies
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Therapeutics

7. Global Cancer Cachexia Market Analysis and Forecast, by Mechanism of Action

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 7.3.1. Appetite Stimulators
    • 7.3.2. Weight Loss Stabilizers
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Mechanism of Action

8. Global Cancer Cachexia Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2023-2031
    • 8.3.1. Hospital Stores
    • 8.3.2. Retail Pharmacy Stores
    • 8.3.3. Online Pharmacies
  • 8.4. Market Attractiveness Analysis, by Mechanism of Action

9. Global Cancer Cachexia Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Cancer Cachexia Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 10.3.1. Progestogens
    • 10.3.2. Corticosteroids
    • 10.3.3. Combination Therapies
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 10.4.1. Appetite Stimulators
    • 10.4.2. Weight Loss Stabilizers
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Distribution Channel, 2023-2031
    • 10.5.1. Hospital Stores
    • 10.5.2. Retail Pharmacy Stores
    • 10.5.3. Online Pharmacies
  • 10.6. Market Value Forecast, by Country, 2023-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Therapeutics
    • 10.7.2. By Mechanism of Action
    • 10.7.3. By Distribution Channel
    • 10.7.4. By Country

11. Europe Cancer Cachexia Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 11.3.1. Progestogens
    • 11.3.2. Corticosteroids
    • 11.3.3. Combination Therapies
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 11.4.1. Appetite Stimulators
    • 11.4.2. Weight Loss Stabilizers
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Distribution Channel, 2023-2031
    • 11.5.1. Hospital Stores
    • 11.5.2. Retail Pharmacy Stores
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Therapeutics
    • 11.7.2. By Mechanism of Action
    • 11.7.3. By Distribution Channel
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Cancer Cachexia Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 12.3.1. Progestogens
    • 12.3.2. Corticosteroids
    • 12.3.3. Combination Therapies
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 12.4.1. Appetite Stimulators
    • 12.4.2. Weight Loss Stabilizers
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Distribution Channel, 2023-2031
    • 12.5.1. Hospital Stores
    • 12.5.2. Retail Pharmacy Stores
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Therapeutics
    • 12.7.2. By Mechanism of Action
    • 12.7.3. By Distribution Channel
    • 12.7.4. By Country/Sub-region

13. Latin America Cancer Cachexia Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 13.3.1. Progestogens
    • 13.3.2. Corticosteroids
    • 13.3.3. Combination Therapies
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 13.4.1. Appetite Stimulators
    • 13.4.2. Weight Loss Stabilizers
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Distribution Channel, 2023-2031
    • 13.5.1. Hospital Stores
    • 13.5.2. Retail Pharmacy Stores
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Therapeutics
    • 13.7.2. By Mechanism of Action
    • 13.7.3. By Distribution Channel
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Cancer Cachexia Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Therapeutics, 2023-2031
    • 14.3.1. Progestogens
    • 14.3.2. Corticosteroids
    • 14.3.3. Combination Therapies
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by Mechanism of Action, 2023-2031
    • 14.4.1. Appetite Stimulators
    • 14.4.2. Weight Loss Stabilizers
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Distribution Channel, 2023-2031
    • 14.5.1. Hospital Stores
    • 14.5.2. Retail Pharmacy Stores
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Therapeutics
    • 14.7.2. By Mechanism of Action
    • 14.7.3. By Distribution Channel
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Aeterna Zentaris, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Alder BioPharmaceuticals Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Aphios Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Eli Lilly and Company
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. GTx Inc.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Helsinn Group
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Merck & Co. Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Novartis AG
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Bristol-Myers Squibb Company
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. XBiotech, Inc.
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 02: Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 03: Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031
  • Table 04: Global Cancer Cachexia Market Size (US$ Bn) Forecast, by Region, 2023-2031
  • Table 05: North America Cancer Cachexia Market Size (US$ Bn) Forecast, by Country, 2023-2031
  • Table 06: North America Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 07: North America Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 08: North America Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031
  • Table 09: Europe Cancer Cachexia Market Size (US$ Bn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 11: Europe Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 12: Europe Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031
  • Table 13: Asia Pacific Cancer Cachexia Market Size (US$ Bn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 15: Asia Pacific Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 16: Asia Pacific Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031
  • Table 17: Latin America Cancer Cachexia Market Size (US$ Bn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 19: Latin America Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 20: Latin America Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031
  • Table 21: Middle East & Africa Cancer Cachexia Market Size (US$ Bn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Cancer Cachexia Market Size (US$ Bn) Forecast, by Therapeutics, 2023-2031
  • Table 23: Middle East & Africa Cancer Cachexia Market Size (US$ Bn) Forecast, by Mechanism of Action, 2023-2031
  • Table 24: Middle East & Africa Cancer Cachexia Market Size (US$ Bn) Forecast, by Distribution Channel, 2023-2031

List of Figures

  • Figure 01: Global Cancer Cachexia Market Size (US$ Bn) and Distribution (%), by Region, 2022 and 2031
  • Figure 02: Global Cancer Cachexia Market Revenue (US$ Bn), by Therapeutics, 2022
  • Figure 03: Global Cancer Cachexia Market Value Share, by Therapeutics, 2022
  • Figure 04: Global Cancer Cachexia Market Revenue (US$ Bn), by Mechanism of Action, 2022
  • Figure 05: Global Cancer Cachexia Market Value Share, by Mechanism of Action, 2022
  • Figure 06: Global Cancer Cachexia Market Revenue (US$ Bn), by Distribution Channel, 2022
  • Figure 07: Global Cancer Cachexia Market Value Share, by Distribution Channel, 2022
  • Figure 08: Global Cancer Cachexia Market Value Share, by Region, 2022
  • Figure 09: Global Cancer Cachexia Market Value (US$ Bn) Forecast, 2023-2031
  • Figure 10: Global Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 11: Global Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 12: Global Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 13: Global Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 14: Global Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 15: Global Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 16: Global Cancer Cachexia Market Value Share Analysis, by Region, 2023 and 2031
  • Figure 17: Global Cancer Cachexia Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Cancer Cachexia Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2022-2031
  • Figure 19: North America Cancer Cachexia Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Cancer Cachexia Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 21: North America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 22: North America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 23: North America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 24: North America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 25: North America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 26:North America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 27: Europe Cancer Cachexia Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2022-2031
  • Figure 28: Europe Cancer Cachexia Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Cancer Cachexia Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 30: Europe Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 31: Europe Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 32: Europe Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 33: Europe Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 34: Europe Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 35: Europe Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 36: Asia Pacific Cancer Cachexia Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2022-2031
  • Figure 37: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 39: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 40: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 41: Asia Pacific Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 42: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 43: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 44: Asia Pacific Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 45: Latin America Cancer Cachexia Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2022-2031
  • Figure 46: Latin America Cancer Cachexia Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Cancer Cachexia Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 48: Latin America Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 49: Latin America Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 50: Latin America Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 51: Latin America Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 52: Latin America Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 53: Latin America Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 54: Middle East & Africa Cancer Cachexia Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2022-2031
  • Figure 55: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 57: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Therapeutics, 2022 and 2031
  • Figure 58: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Mechanism of Action, 2022 and 2031
  • Figure 59: Middle East & Africa Cancer Cachexia Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 60: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Therapeutics, 2023-2031
  • Figure 61: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Mechanism of Action, 2023-2031
  • Figure 62: Middle East & Africa Cancer Cachexia Market Attractiveness Analysis, by Distribution Channel, 2023-2031